
An experimental drug kills fat cells, rather than shrinking them
In two small trials, people lost dangerous visceral fat around their internal organs
Read the storyReporting and perspectives on clinical trials.

In two small trials, people lost dangerous visceral fat around their internal organs
Read the story
In two small trials, people lost dangerous visceral fat around their internal organs
Read the story
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Read the storyHave a story worth telling? Share a tip, a question or a perspective in the Feed.
Start a conversation